EU Crunch Time For Myriad Drugs Marks A Busy May Meeting For CHMP

 
• By Neena Brizmohun

The latest meeting of the European Medicines Agency’s human medicines committee, the CHMP, is taking place this week. Decisions are expected for 13 drug marketing applications, there will be a number of oral explanation meetings, and activity is expected relating to a drug at the center of a case involving the European Commission’s rejection of an EMA recommendation.

gene therapy pills
Another hemophilia B gene therapy could be approved in the EU soon • Source: Shutterstock

More from Product Reviews

More from Pink Sheet